Phospho-Histone H3 (Ser28) Antibody

What is Phospho-Histone H3 (Ser28) and why is it significant in epigenetic research?

Phospho-Histone H3 (Ser28) refers to the phosphorylated form of histone H3 at the serine 28 position. This 15 kDa protein is a fundamental component of eukaryotic chromatin that plays a critical role in forming nucleosome structure. The phosphorylation of histone H3 at serine 28 represents a significant post-translational modification that influences chromatin dynamics during cellular processes. In epigenetic research, this modification serves as a crucial marker for specific cellular states, particularly during mitosis. The phosphorylation state of histone H3 contributes to the regulation of chromatin condensation and transcriptional activity, making it an invaluable target for studies focused on cell cycle progression, gene expression, and cellular responses to environmental stimuli. This modification also interacts with other histone marks to establish complex epigenetic codes that govern cellular function .

How does Phospho-Histone H3 (Ser28) differ from other histone modifications?

Phospho-Histone H3 (Ser28) represents a distinct histone modification with unique biological implications compared to other histone modifications. Unlike acetylation or methylation which primarily affect chromatin accessibility for transcription, phosphorylation at serine 28 is predominantly associated with chromosome condensation during mitosis. This modification differs from the closely related phosphorylation at serine 10 in terms of timing, distribution patterns, and functional outcomes. While both serine 10 and serine 28 phosphorylation occur during mitosis, they show different temporal dynamics and can be regulated by distinct kinases. Additionally, phosphorylation at serine 28 is uniquely mediated by MSK1 following activation of the MAP kinase signaling pathway in response to specific stimuli including tumor promoters (e.g., UV and EGF) and oncoproteins (e.g., c-Myc, c-Jun, and c-Fos). This specific signaling context distinguishes it from other histone modifications and links it to particular cellular processes including cell transformation and regulation of RNA polymerase III transcription machinery .

What is the temporal pattern of Histone H3 Ser28 phosphorylation during mitosis?

Histone H3 Ser28 phosphorylation displays a highly regulated temporal pattern during mitotic progression. The phosphorylation becomes detectable at the onset of mitosis, specifically during prophase, reaches its maximum intensity during metaphase, and begins to diminish during the early stages of anaphase. Importantly, the HTA28 antibody does not detect this modification during late anaphase, indicating a precise dephosphorylation event that occurs as chromosomes segregate. This temporal specificity makes phospho-histone H3 (Ser28) an excellent marker for tracking mitotic progression in cellular populations. The precise timing of this phosphorylation correlates with chromosome condensation events, suggesting its functional role in organizing chromatin structure during cell division. Researchers can leverage this temporal pattern to distinguish between different mitotic phases when studying cell cycle dynamics or analyzing the effects of cell cycle-disrupting compounds .

What are the optimal protocols for detecting Phospho-Histone H3 (Ser28) in flow cytometry experiments?

For optimal detection of Phospho-Histone H3 (Ser28) in flow cytometry experiments, researchers should implement specific fixation and permeabilization protocols that preserve the phospho-epitope while allowing antibody access to nuclear targets. The recommended approach involves a two-step protocol rather than a one-step procedure. Specifically, Protocol A (for intracellular cytoplasmic proteins) or Protocol C (Fixation/Methanol) are recommended, while Protocol B (one-step protocol for nuclear proteins) should be avoided for this application. For the HTA28 monoclonal antibody, pre-titrated amounts of approximately 0.25-0.5 μg per test or 5 μL per test (depending on the specific conjugate) have been validated for optimal staining. The cell sample should be prepared in a final volume of 100 μL, with cell numbers ranging from 10^5 to 10^8 cells per test based on empirical determination for each specific cell type. For enhanced detection of mitotic cells, pretreatment with nocodazole to enrich for mitotic populations has been validated in HeLa cells. When using fluorochrome-conjugated versions like eFluor 660, ensure your instrument has appropriate lasers and filters (Excitation: 633-647 nm; Emission: 668 nm) .

How should researchers optimize immunohistochemistry protocols for Phospho-Histone H3 (Ser28) antibody?

Optimizing immunohistochemistry protocols for Phospho-Histone H3 (Ser28) antibody requires careful consideration of several critical parameters to ensure specific detection while minimizing background. For formaldehyde-fixed paraffin-embedded tissues, antigen retrieval is essential as the fixation process can mask the phospho-epitope. Heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 8.0) should be empirically tested to determine optimal conditions. For immunohistochemistry applications, a recommended antibody dilution range of 1:10 to 1:2000 should be tested, with exact concentrations determined through titration experiments on appropriate control tissues. Fixation methodology significantly impacts epitope preservation, with 3.7% formaldehyde-methanol fixation specifically recommended for immunocytochemistry applications. For frozen sections, acetone fixation for 10 minutes at room temperature offers good preservation of the phospho-epitope. When developing the signal, researchers should select detection systems compatible with rat IgG primary antibodies, as the HTA28 clone is a rat-derived monoclonal. Finally, include positive controls (tissues with known mitotic activity) and negative controls (primary antibody omission and unphosphorylated controls) to validate staining specificity .

What are the validated applications for Phospho-Histone H3 (Ser28) antibody beyond standard Western blotting?

Phospho-Histone H3 (Ser28) antibody (HTA28) has been validated for numerous applications beyond standard Western blotting, offering researchers versatile tools for studying this modification in various experimental contexts. Flow cytometry represents a powerful application, allowing quantitative assessment of mitotic cells in heterogeneous populations with the ability to correlate phospho-H3(Ser28) status with other cellular parameters. Immunocytochemistry and immunofluorescence techniques permit visualization of the spatial distribution of this modification within individual cells, revealing its nuclear localization and correlation with chromosomal structures during mitosis. The antibody has also been validated for various immunohistochemistry applications, including protocols for frozen sections, paraffin-embedded tissues, and specialized microarray platforms. This versatility allows researchers to examine the modification in diverse biological contexts, from cultured cells to complex tissues. Each application requires specific optimization parameters, including different recommended antibody concentrations ranging from 0.5-1.0 μg/ml for Western blotting to more dilute preparations (1:10-1:2000) for immunofluorescence applications .

How can researchers effectively use Phospho-Histone H3 (Ser28) antibody to quantify mitotic index?

Researchers can effectively quantify mitotic index using Phospho-Histone H3 (Ser28) antibody through several validated methodological approaches. Flow cytometry offers a high-throughput approach where cells are fixed, permeabilized, and stained with the antibody, allowing rapid quantification of the percentage of cells in mitosis within large populations. For this application, researchers should follow a two-step protocol using either Protocol A (for intracellular cytoplasmic proteins) or Protocol C (Fixation/Methanol), with antibody concentrations of approximately 0.25-0.5 μg per test. Alternatively, immunofluorescence microscopy provides spatial information by visualizing individual mitotic cells, which can be counted relative to the total cell population using DAPI counterstaining for all nuclei. For tissues, immunohistochemistry with the HTA28 antibody enables assessment of mitotic index in complex tissue environments. When comparing treatment conditions, nocodazole treatment can serve as a positive control by arresting cells in mitosis and elevating the mitotic index. Importantly, researchers should note that the antibody specifically detects the phosphorylated histone molecule during prophase and metaphase, with weaker detection at the beginning of anaphase and no detection during late anaphase, providing temporal resolution of mitotic progression .

How does MSK1-mediated phosphorylation of Histone H3 at Ser28 regulate transcriptional activation?

MSK1-mediated phosphorylation of Histone H3 at Ser28 regulates transcriptional activation through a complex mechanism involving chromatin remodeling and transcription factor recruitment. This phosphorylation event occurs downstream of MAP kinase signaling pathway activation in response to specific stimuli including tumor promoters (UV, EGF) and oncoproteins (c-Myc, c-Jun, c-Fos). When MSK1 becomes activated, it phosphorylates Ser28 on histone H3, which disrupts interactions between the histone tail and DNA, contributing to a more accessible chromatin configuration. This modification works synergistically with other histone marks, particularly acetylation, to establish transcriptionally permissive chromatin states. Beyond its structural effects, phosphorylation at Ser28 creates binding sites for effector proteins that further recruit transcriptional machinery components. Studies have demonstrated that this modification particularly impacts RNA polymerase III transcription machinery, influencing the expression of small nuclear RNAs and transfer RNAs. This mechanism represents a direct link between extracellular signaling cascades and specific transcriptional responses, allowing cells to rapidly adapt gene expression in response to environmental changes or developmental cues .

How can researchers distinguish between the mitotic and interphase functions of Histone H3 Ser28 phosphorylation?

Distinguishing between mitotic and interphase functions of Histone H3 Ser28 phosphorylation requires sophisticated experimental approaches that address both temporal dynamics and functional contexts. To differentiate these functions, researchers should implement cell synchronization protocols to obtain populations enriched in specific cell cycle phases. This can be achieved using double thymidine block for G1/S phase enrichment, followed by release into normal growth media with time-point sampling, or nocodazole treatment for mitotic enrichment. Co-immunostaining for Phospho-Histone H3 (Ser28) with cell cycle markers such as cyclin B1 (mitotic marker) or Ki-67 (proliferation marker) can help correlate the modification with specific cell cycle stages. For interphase-specific functions, researchers should examine Ser28 phosphorylation following specific signaling pathway activations (EGF, UV) in serum-starved cells to eliminate mitotic contributions. Chromatin immunoprecipitation (ChIP) assays using Phospho-Histone H3 (Ser28) antibody under different cellular conditions can identify genomic regions associated with this modification during interphase versus mitosis. Additionally, pharmacological inhibitors of MSK1 or upstream kinases can help dissect the signaling requirements for Ser28 phosphorylation in different cellular contexts .

What are the established interactions between Histone H3 Ser28 phosphorylation and other epigenetic modifications?

Histone H3 Ser28 phosphorylation participates in complex interactions with other epigenetic modifications, creating a sophisticated histone code that regulates chromatin structure and function. Research has established that phosphorylation at Ser28 can influence adjacent histone modifications through various mechanisms. This modification shows a significant interplay with methylation at lysine 27 (K27), where phosphorylation at Ser28 can displace Polycomb repressive complex proteins bound to the trimethylated K27, resulting in derepression of developmental genes. Additionally, Ser28 phosphorylation works cooperatively with acetylation at various lysine residues, particularly during transcriptional activation in response to stress stimuli. The temporal relationship between these modifications is critical, with evidence suggesting that Ser28 phosphorylation can precede and potentially facilitate subsequent acetylation events. During mitosis, the combination of Ser28 phosphorylation with Ser10 phosphorylation contributes to the establishment of the unique chromatin environment required for proper chromosome condensation and segregation. These interactions create context-specific outputs that allow the same chemical modification to participate in diverse cellular processes ranging from transcriptional regulation to mitotic progression .

What are common challenges in detecting Phospho-Histone H3 (Ser28) and how can they be overcome?

Detecting Phospho-Histone H3 (Ser28) presents several common challenges that researchers can systematically address through specific methodological adjustments. Epitope masking during fixation represents a primary difficulty, particularly with cross-linking fixatives that can obscure the phospho-epitope. This can be overcome by optimizing fixation protocols, with 3.7% formaldehyde-methanol fixation specifically recommended for immunocytochemistry applications. Phosphatase activity during sample preparation can lead to false negatives by dephosphorylating the target epitope; researchers should incorporate phosphatase inhibitors (e.g., sodium fluoride, β-glycerophosphate, sodium orthovanadate) in all buffers until fixation is complete. Low signal intensity, particularly in tissues with few mitotic cells, can be addressed by implementing signal amplification systems such as tyramide signal amplification or using more sensitive detection methods. Non-specific background staining, especially in immunohistochemistry applications, can be minimized through optimal blocking procedures using species-appropriate normal sera or protein solutions. Finally, for flow cytometry applications, researchers should note that Protocol B (one-step protocol for nuclear proteins) is not suitable for this antibody, and should instead use Protocol A or Protocol C as recommended in the technical documentation .

How can researchers validate the specificity of Phospho-Histone H3 (Ser28) antibody staining?

Validating the specificity of Phospho-Histone H3 (Ser28) antibody staining requires multiple complementary approaches to establish confidence in experimental results. Peptide competition assays represent a gold standard approach, where pre-incubation of the antibody with phosphorylated peptide should abolish staining while pre-incubation with unphosphorylated peptide should not affect signal. Lambda phosphatase treatment of samples provides another critical control, as this treatment should eliminate specific staining by removing the phosphate group from serine 28. Researchers should also implement biological validation using treatments known to increase mitosis (e.g., nocodazole) which should enhance the percentage of phospho-H3(Ser28)-positive cells. Correlation with independent mitotic markers such as phospho-H3(Ser10) or MPM-2 can provide additional confirmation of specificity. Knockout/knockdown validation offers definitive evidence, though for histone H3 this may require specialized approaches due to multiple gene copies. Serial dilution of the antibody should produce a consistent staining pattern with decreasing intensity rather than revealing off-target binding at higher concentrations. Finally, comparison across multiple detection methods (e.g., Western blot, immunofluorescence, flow cytometry) should yield consistent results regarding the cell cycle specificity of the modification .

What factors should researchers consider when selecting between different Phospho-Histone H3 (Ser28) antibody conjugates?

When selecting between different Phospho-Histone H3 (Ser28) antibody conjugates, researchers should consider multiple experimental factors to optimize detection and compatibility with their specific applications. Instrument compatibility represents the primary consideration for flow cytometry applications, with different fluorophores requiring specific laser excitation and emission filter configurations. For example, the eFluor 660 conjugate requires excitation at 633-647 nm and detection at 668 nm, necessitating a red laser, while Alexa Fluor 488 conjugates require blue laser excitation. Experimental design involving multiple markers requires careful panel design to avoid spectral overlap, with conjugate selection based on the relative abundance of targets (brighter fluorophores for less abundant targets). For immunofluorescence applications, consider tissue autofluorescence characteristics when selecting conjugates, potentially avoiding green fluorophores in tissues with significant autofluorescence in this range. The stability of different conjugates under experimental conditions varies, with some fluorophores being more photostable or pH-resistant than others. Detection sensitivity requirements should guide selection between directly conjugated antibodies (simpler protocol) versus unconjugated primary antibodies with secondary detection (higher sensitivity). Finally, for specialized applications like intravital imaging or super-resolution microscopy, specific conjugates may offer superior performance characteristics .

How should researchers optimize antibody concentration for different experimental systems?

Optimizing antibody concentration for different experimental systems requires systematic titration approaches tailored to the specific application and biological context. For Western blot applications, researchers should begin with the recommended concentration range of 0.5-1.0 μg/ml and perform a dilution series to identify the concentration that provides optimal specific signal with minimal background. For immunocytochemistry and immunofluorescence applications, a much wider recommended range (1:10-1:2000 dilution) necessitates more extensive titration, ideally on positive control samples with known phospho-H3(Ser28) expression. Flow cytometry applications require titration starting from the recommended 0.25-0.5 μg per test or 5 μL per test (depending on the conjugate), testing at least 5 concentrations to generate a titration curve that identifies the optimal signal-to-noise ratio. For all applications, titration should include appropriate negative controls to assess background. Different biological systems may require distinct optimal concentrations; for example, tissue sections typically require higher antibody concentrations than cultured cells due to increased background binding and reduced epitope accessibility. When transitioning between different detection systems (e.g., from chromogenic to fluorescent detection in immunohistochemistry), re-optimization is necessary. Finally, batch-to-batch variation may necessitate re-titration when using a new antibody lot, particularly for quantitative applications .

How is Phospho-Histone H3 (Ser28) implicated in cellular responses to stress and oncogenic signaling?

Phospho-Histone H3 (Ser28) plays critical roles in cellular responses to stress and oncogenic signaling through its position as a downstream effector of the MAP kinase signaling pathway. When cells encounter stress stimuli such as UV radiation or growth factors like EGF, these signals activate the MAP kinase cascade, leading to MSK1 activation and subsequent phosphorylation of histone H3 at serine 28. This modification triggers specific transcriptional programs associated with stress response and cell survival. In the context of oncogenic signaling, the phosphorylation of H3 at Ser28 has been directly linked to the activity of oncoproteins including c-Myc, c-Jun, and c-Fos, establishing a mechanistic connection between oncogene activation and epigenetic reprogramming. This phosphorylation event contributes to cell transformation processes by altering the expression patterns of genes involved in cell proliferation, survival, and metabolic adaptation. Importantly, the dual role of phospho-H3(Ser28) in both transcriptional regulation and mitotic progression suggests that stress-induced alterations in this modification may have complex effects on cellular phenotypes by simultaneously affecting gene expression patterns and cell division dynamics. This positions phospho-H3(Ser28) as a potential integrator of stress signaling and cell cycle regulation pathways .

What novel methodologies are being developed to study the dynamics of Histone H3 Ser28 phosphorylation?

Novel methodologies for studying Histone H3 Ser28 phosphorylation dynamics are advancing our understanding of this epigenetic modification across multiple dimensions. Live-cell imaging approaches using fluorescent antibody fragments or phospho-specific intrabodies enable real-time visualization of phosphorylation events during cell cycle progression or in response to signaling stimuli. Mass spectrometry-based techniques, particularly targeted approaches like parallel reaction monitoring (PRM) or multiple reaction monitoring (MRM), offer quantitative assessment of phosphorylation stoichiometry and co-occurrence with other modifications on the same histone tail. Single-cell epigenomic approaches are being adapted to examine phospho-H3(Ser28) distribution across heterogeneous cell populations, revealing cell-to-cell variability in modification patterns. Genome-wide mapping techniques combining chromatin immunoprecipitation with high-throughput sequencing (ChIP-seq) or CUT&RUN methodologies provide high-resolution maps of phospho-H3(Ser28) distribution across the genome under different conditions. CRISPR-based epigenome editing approaches using catalytically inactive Cas9 fused to kinases or phosphatases allow researchers to manipulate phosphorylation at specific genomic loci to assess functional outcomes. Finally, computational approaches integrating multiple histone modification datasets are revealing the complex interplay between phospho-H3(Ser28) and other chromatin marks in establishing specific functional chromatin states .

How might targeting Histone H3 Ser28 phosphorylation pathways impact therapeutic strategies?

Targeting Histone H3 Ser28 phosphorylation pathways offers promising therapeutic strategies across multiple disease contexts, particularly in oncology and inflammatory disorders. Since MSK1-mediated phosphorylation of H3 at Ser28 occurs downstream of MAP kinase signaling pathways that are frequently dysregulated in cancer, inhibitors targeting this specific phosphorylation event might provide more selective therapeutic approaches compared to broadly targeting upstream kinases. The established role of phospho-H3(Ser28) in cell transformation processes suggests that modulating this modification could potentially interrupt oncogenic transcriptional programs without broadly affecting all MAP kinase-dependent processes. In mitotic contexts, the specificity of H3 Ser28 phosphorylation during prophase and metaphase suggests therapeutic opportunities for targeting cells with aberrant mitotic progression. For inflammatory conditions, where MSK1 activation contributes to pro-inflammatory gene expression programs, targeting H3 Ser28 phosphorylation might provide anti-inflammatory effects with potentially fewer side effects than current therapeutic approaches. Developing therapeutic strategies could focus on several approaches: direct inhibition of MSK1 kinase activity, disruption of interactions between phosphorylated H3 Ser28 and its binding partners, or targeting the downstream effectors that interpret this histone modification. The development of such targeted approaches would benefit from deeper understanding of tissue-specific functions and context-dependent roles of this modification .